Translumina unveils dual-drug polymer-free coated stent in international markets

19 April 2022 | News

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey

Image credit:

Image credit:

New Delhi-based Translumina has launched VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets including Europe. 


VIVO ISAR is the first Dual Drug Polymer-Free Coronary Stent technology, which brings together a stent with a superior safety profile without compromising the drug release kinetics. 


VIVO ISAR is the first technology that uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenotic drug) and thus creates a polymer-free DES platform with uncompromised safety and efficacy. 


Translumina has launched VIVO ISAR in Italy & Spain and plans to roll it out in several markets across EuropeLatin America and APAC over the coming months. 



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account